Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab

MeSH terms

• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Cisplatin / administration & dosage
• Cisplatin / therapeutic use
• Combined Modality Therapy
• Cytarabine / administration & dosage
• Cytarabine / therapeutic use
• Dexamethasone / administration & dosage
• Dexamethasone / therapeutic use
• Humans
• Leukemia, Hairy Cell / drug therapy*
• Leukemia, Hairy Cell / genetics
• Leukemia, Hairy Cell / therapy
• Male
• Middle Aged
• Remission Induction
• Rituximab
• Stem Cell Transplantation